1 Department of Pathology, Division of Molecular and Cellular Pathology, 2 Center for Surgical Research and Department of Surgery, and 3 Department of Physiology and Biophysics, The University of Alabama at Birmingham, Birmingham, Alabama 35294
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Hyperglycemia is an early metabolic response to trauma and hemorrhage. The role of hepatic insulin resistance to the development of this hyperglycemia is not well understood. The aim of this study was to determine whether the liver becomes insulin resistant and to identify the particular hepatic insulin signaling pathways that may be compromised following trauma and hemorrhage. Male adult rats were bled to a mean arterial pressure of 40 mmHg and maintained at that pressure for 90 min followed by resuscitation with Ringer lactate. Data showed that trauma and hemorrhage rapidly induced profound hyperinsulinemia in combination with significant hyperglycemia, suggesting the development of insulin resistance. After trauma and hemorrhage, hepatic insulin signaling via the insulin-induced phosphatidylinositol 3 (PI3)-kinase-Akt pathway was abolished, whereas ERK1/2 signaling was relatively normal. The regulation (inhibition) of a hepatic-, insulin-, and the PI3-kinase-dependent gene, IGF binding protein-1, was also lost. The present study provides convincing evidence of a rapid onset hepatic insulin resistance following a combination of trauma and hemorrhage.
liver; shock
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
VARIOUS PATHOPHYSIOLOGICAL conditions such as surgical trauma, hemorrhage, shock, sepsis, and burns often result in a hypermetabolic state in which energy expenditure is increased (5, 19, 38). As part of this physiological response, there is often increased protein degradation in muscle, at least partially due to development of muscle insulin resistance. Hyperglycemia ensues due to decreased peripheral glucose disposal, often coincident with hyperinsulinemia (27, 43, 51). The hyperglycemia, sometimes referred to as "stress diabetes," could be readily explained by either insulin deficiency or insulin resistance. In less severe forms of stress, a transient decrease in circulating insulin is sometimes found (6, 21, 39). However, in most clinical and experimental situations, there is an increase in insulin in addition to the development of hyperglycemia (24, 44). This hyperglycemia in the face of elevated insulin is commonly referred to as insulin resistance.
Insulin resistance in peripheral tissues, primarily muscle and fat, results in decreased glucose uptake (reduced glucose clearance) by these tissues. Insulin is one of the primary suppressors of hepatic gluconeogenesis and hepatic glucose output, and the hyperinsulinemia should work to decrease hepatic gluconeogenesis. However, if the liver becomes resistant to insulin, the increased hepatic glucose output can contribute to the hyperglycemia. Recently, there is evidence that expression of at least one hepatic gluconeogenic gene (glucose-6-phosphatase) is altered following hemorrhage or sepsis (1, 31, 33), but the relationship between the development of hepatic insulin resistance and altered expression of this gene is unknown.
Although hyperglycemia is an early metabolic response to trauma and hemorrhage, the mechanisms responsible for this hyperglycemia remain unclear. By measurement of insulin-induced glucose uptake in isolated soleus muscle, Chaudry and co-workers (7) reported that following the combination of surgical trauma and hemorrhage, rat skeletal muscle insulin resistance was evident by as early as 2 h. However, it is unknown whether hepatic insulin resistance also occurs in this model.
Insulin signaling consists of a cascade of phosphorylation events carried out by protein and lipid kinases (41, 61). Autophosphorylation of the receptor further phosphorylates insulin receptor substrates (IRS), which serve as "docking" molecules, favoring the generation of intracellular signals (40, 60). There are at least two main branches that propagate insulin intracellular signaling: IRS/phosphatidylinositol 3-kinase (PI3-kinase)-Akt pathway and the Ras/mitogen-activated protein kinase (MAPK) pathway, which includes ERK1/2 (30, 41). Insulin resistance refers to a decreased capacity of target cells to respond to ordinary levels of circulating insulin due to impairment of one or more signaling pathways.
In the present study, a rat model of soft tissue trauma and hemorrhage has been used to delineate the cellular mechanisms of hepatic insulin resistance. Changes in insulin signaling pathways were characterized as well as changes in blood glucose and insulin levels following trauma and hemorrhagic shock. Defects in insulin signaling were selective and resulted in alterations in insulin-dependent, signaling pathway-specific, gene expression.
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animal model of surgical trauma and hemorrhage. All procedures were carried out in accordance with the guidelines set forth in the Animal Welfare Act and the Guide for the Care and Use of Laboratory Animals by the National Institutes of Health. A model of trauma and hemorrhage in the rat, as previously described by Chaudry et al. (9) and Wang et al. (59) was used in this study with minor modifications. Male Sprague-Dawley rats (275-325 g, Charles River labs, Wilmington, MA) were fasted 18-20 h before the experiment but were allowed water ad libitum. The rats were anesthetized with ether inhalation. After rats were clipped and shaved, they were restrained in a supine position and were kept anesthetized by continued inhalation of 1.5% isoflurane (Mallinckrodt Veterinary, Mundelein, IL) and 98.5% air throughout the surgical procedure. While anesthetized, a 5-cm ventral midline laparotomy was performed representing soft tissue trauma. The abdomen was then closed in layers using 4-0 Ethilon sutures (Ethicon, Somerville, NJ), and the wounds were bathed with 1% lidocaine (Elkins-Sinn, Cherry Hill, NJ) throughout the surgical procedure to reduce postoperative pain. Polyethylene-50 catheters (Clay-Adams, Parsippany, NJ) were placed in the right and left femoral arteries and the right femoral vein for bleeding, monitoring of mean arterial pressure (MAP), and fluid resuscitation, respectively. Blood pressure was constantly monitored by attaching one of the catheters to a blood pressure analyzer (Micro-Med, Louisville, KY). The rats were then bled to a MAP of 40 mmHg within 10 min. Once MAP reached 40 mmHg, the timing of the hemorrhage period began and was maintained for 90 min. At the end of the hemorrhage period, the rats were resuscitated with four times the withdrawn blood volume using Ringer lactate infused by syringe pump (Harvard Apparatus, South Natick, MA) at a constant rate over 60 min. Sham-operated rats underwent the same surgical procedure (laparotomy and catheterization), but neither hemorrhage nor resuscitation was carried out.
Experimental design. Due to the considerable trauma incurred by anesthesia and opening of the abdominal cavity to perform the insulin injections (see next section), it was impossible to have a completely untreated control group. Thus the "baseline" animal was selected in these experiments to be the trauma-alone group (T 0'), which was subjected to anesthesia, laparotomy, and catheterization and then killed immediately. Additional trauma-alone groups were subjected to these same procedures and then killed at 90' (T 90') or 210' (T 210') after catheterization. Matched to these groups were the trauma plus hemorrhage (TH) groups, which were subjected to the same procedures as the T groups, but were also subjected to hemorrhage and then killed at 90 min just at the end of the hemorrhage period (TH 90') or 60 min following completion of the 60-min resuscitation period (TH 210' = 90 min hemorrhage + 60 min resuscitation + 60 min recovery).
Blood and tissue harvesting procedures. At the 0', 90', or 210' time points, the abdominal cavity was opened again, the portal vein was exposed, and 5 U insulin in saline or saline alone (0.5 ml) were injected into the portal vein. This large dose of insulin was chosen because it was found to be optimal for induction of insulin signaling pathways in liver as well as other peripheral tissues (17). Unless otherwise noted, 1 min following the injection, livers were removed and quickly frozen in liquid nitrogen.
Measurement of glucose and insulin levels.
Just before insulin or saline injection, blood was withdrawn, and
glucose levels were measured in 0.2 ml whole blood using a Radiometer
ABL 700 Series (Radiometer American, Westlake, OH). For insulin levels,
0.5 ml blood were placed at room temperature, allowed to coagulate, and
then centrifuged at 5,000 g for 15 min. The serum was stored
at 80°C until insulin levels were measured by a rat insulin RIA kit
(Linco Research, St. Charles, MO).
Western immunoblots.
Liver tissue from each animal (~0.2 gram) was homogenized in 1 ml
lysis buffer containing 20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 20 mM KCl, 20% glycerol, 0.2 mM EDTA, 2 mM
Na3Vo4, 10 mM NaF, 1% Triton X-100, 0.2 mM
PMSF, 10 mg/ml aprotinin, and 10 mg/ml leupeptin. Tissue lysates were
centrifuged at 10,000 g for 10 min, and the supernatants
were stored at 80°C until use. Tissue lysate protein concentrations
were assayed (Bio-Rad Laboratories, Hercules, CA), and lysates (15 µg/lane) were then resolved by SDS, 10% PAGE, and transferred to
nitrocellulose paper. The Western transfers were immunoblotted with
anti-phospho-ERK1/2, anti-total ERK1/2, and anti-phospho-Akt (Cell
Signaling Technology, Beverly, MA) followed by the addition of
horseradish peroxidase-conjugated secondary antibody for detection of
bound antibody by enhanced chemiluminescence (ECL; Amersham Pharmacia
Biotech, Piscataway, NJ). Each blot was stripped 30 min at 50°C in
stripping buffer (100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM
Tris · HCl, pH 6.7) and then reprobed with a
different antibody.
Northern blot hybridization analysis. Total hepatic RNA was isolated by the Ultraspec RNA isolation system (Biotecx Laboratories, Houston, TX). Total RNA (10 µg) from each animal was subjected to formaldehyde gel electrophoresis and transferred to nylon membrane (Ambion, Austin, TX) as described previously (36). IGF binding protein (IGFBP)-1 cDNA probe was radiolabeled with [32P]dCTP using Prime-It II random primer labeling kit (Stratagene, La Jolla, CA), and blots were incubated with this probe overnight, washed, and autoradiographed.
Densitometric and statistical analysis. ECL images of immunoblots and Northern signal intensity were scanned and quantified with a Scanalytics Zero D-Scan. All data were analyzed by one-way ANOVA using the InStat Statistical program (version 3) by GraphPad Software (San Diego, CA).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Trauma and hemorrhage induce hyperglycemia and hyperinsulinemia.
Blood glucose levels following trauma alone increased slightly at both
90 and 210 min compared with T 0' animals from 97 to 121 and 123 mg/dl,
respectively. This increase in blood glucose was most likely due to a
moderate degree of insulin resistance resulting from the continued
anesthesia and/or developed over time following the trauma of the
surgical procedures. However, surgical trauma followed by hemorrhage
for 90 min (immediately before resuscitation; TH 90') resulted in a
significant increase in blood glucose levels to 156 mg/dl and further
increased to 178 mg/dl at 60 min after the completion of fluid
resuscitation (i.e., TH 210'; Fig.
1A). This is suggestive of
insulin resistance, because blood glucose levels are usually tightly
controlled. This resistance develops rapidly following hemorrhage and
is not altered by fluid resuscitation.
|
Time course of hepatic insulin signaling responding to insulin
injection.
Experiments were performed to measure whether there were any changes in
insulin signaling following surgical trauma and hemorrhage. Immediately
following surgery alone (T 0'), animals were injected with a bolus
injection of 5 U insulin into the hepatic portal vein. One minute after
insulin injection, there was an increase in phosphorylation of Akt
(P-Akt; Fig. 2A) and
phosphorylation of ERK1/2 (P-ERK1/2; Fig. 2B). When
additional time points were attempted, it was clear that of the time
points attempted (3 and 5 min postinjection), a maximal response was
obtained on both P-Akt and P-ERK at 1 min. These effects were decreased
by 3 min and returned to basal values by 5 min following insulin
injection (Fig. 2, A and B), consistent with
previously published data (17).
|
Alterations in insulin-induced P-Akt signaling in the liver.
The data presented in Fig. 2A indicated that there was a
complete loss of the P-Akt response to exogenous insulin following TH
at 90' (Fig. 2A). Additional studies were performed and
confirmed that there was little or no induction of P-Akt by insulin at
both TH 90' and TH 210', the two time points following both trauma and
hemorrhage, although there was no change in total Akt levels. However,
most importantly, there was still an insulin induction of P-Akt at
these same time points in the trauma-only groups (T 90' and T 210';
Fig. 3A).
When using the antibody that recognizes the total amount of Akt, it was
clear that when the liver responded to insulin by an increase in P-Akt
(at T 0', T 90', and T 210'), there was also an upward shift in the
mobility of the Akt protein on Western blots. However, when the hepatic
PI3-kinase-Akt pathway was unresponsive to insulin (TH 90' and TH
210'), there was no upward mobility shift of the Akt protein (Fig.
3A).
|
Alterations in insulin-induced P-ERK1/2 signaling in the liver. Unlike phosphorylation of P-Akt, insulin-induced phosphorylation of ERK1/2 was evident following trauma and hemorrhage. When the same blots used to measure changes in P-Akt were reprobed with an antibody specific for P-ERK1/2, the results were markedly different. In the trauma-only groups, there was little observable change in basal P-ERK1/2 (without insulin) at either of the time points (T 90' or T 210'). However, after the combination of trauma and hemorrhage, there was a significant increase of basal (without insulin) P-ERK at both 90 and 210 min, with no change in total ERK1/2 levels (Fig. 3A). When the results from multiple experiments were averaged, there were 10-fold increases in basal P-ERK2 following trauma and hemorrhage compared with the T 0' group as well as the time-matched trauma-only groups (Fig. 3C).
Induction of P-ERK1/2 by insulin injection was then examined in the animals subjected to trauma and hemorrhage. In Fig. 3A, it is evident that there was still a significant induction of P-ERK1/2 following 1 min of insulin injection, although basal levels were elevated (Fig. 3C). When multiple experiments were quantified, injections of insulin resulted in a 17- to 20-fold increase in P-ERK2. This effect varied little in animals immediately following surgery (T 0' + insulin) or in the other trauma-only groups (T 90' and T 210'; Fig. 3D). However, after trauma and hemorrhage, the final increase was 33- and 31-fold in the TH 90' and TH 210' groups, respectively, compared with T 0' rats not treated with insulin. This level is significantly increased compared with the time-matched trauma-only animals. These data indicate the continued responsiveness to insulin following hemorrhage. If the elevated baseline in the trauma plus hemorrhage animals without exogenous insulin (9.5- to 10.5-fold) were first subtracted, exogenous insulin resulted in the increase of P-ERK2 of 22- to 23-fold (Fig. 3D, right). This level of fold induction is similar to the effects of exogenous insulin in the trauma-only animals and demonstrates that when administered via the portal vein to rats following the combination of trauma and hemorrhage, exogenous insulin was still capable of inducing a large increase in P-ERK1/2 on top of the already elevated P-ERK1/2 levels.Alterations in IGFBP-1 gene expression in rat liver following
hemorrhage.
Insulin normally inhibits the expression of IGFBP-1 mRNA (46,
47) and requires the PI3-kinase pathway for this effect. Because
there was a defect in the PI3-kinase signaling pathway following TH, it
was asked whether this loss of PI3-kinase signaling resulted in a loss
of insulin inhibition of the IGFBP-1 gene. Northern analysis
indicated that there was an increase of 1.9- and 6.7-fold of IGFBP-1
mRNA in the T groups at the 90' and 210', respectively, compared with
the T 0' group (Fig. 4). This was not
surprising because there was development of a mild insulin resistance
in response to the stress of surgery. However, there was a much greater
induction of IGFBP-1 gene expression, rising to 21- and
28-fold by 90' and 210' in the TH groups, respectively (Fig. 4).
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Hyperglycemia occurs following sepsis (11, 33), surgery (35, 37, 45), and hemorrhage (33). This injury/infection-induced hyperglycemia, often referred to as "stress diabetes," could be readily explained by either insulin deficiency or insulin resistance. There is an increasing body of literature concerning insulin resistance in muscle and adipose tissue, with much less known about hepatic insulin resistance. In some models of sepsis, hepatic insulin resistance has been observed, whereas in other reports, no hepatic insulin resistance was found even with demonstrable peripheral insulin resistance (23, 29). Although the sequelae of trauma and hemorrhage remain a major cause of mortality in surgical intensive care units, it is unknown whether hepatic insulin resistance occurs, and if so, what are the cellular mechanisms responsible for this resistance. In this study, a well-established rat model of trauma and hemorrhage (3, 8, 9, 58) was used to examine changes of blood glucose and insulin levels and to determine whether hepatic insulin resistance develops. The cellular mechanisms of hepatic insulin resistance was also investigated by examining insulin signal-transduction pathways and insulin regulation of hepatic gene expression.
In the present study, three time points were selected: at the end of
the soft-tissue injury (T 0'); at the end of a hemorrhage period, if
performed (TH 90' or T 90'), which allows examination of the effects of
hemorrhage without the effects of fluid resuscitation; or 60 min after
completion of the 60-min resuscitation period (TH 210' if hemorrhage
was performed; T 210' if no hemorrhage). Previous work suggests
that cytokines, such as TNF-, which may be one of the causes of
insulin resistance, are significantly increased by the end of the
hemorrhage period and for 4-6 h after resuscitation
(2). Additionally, ischemia-reperfusion injury of
organs, such as the heart, can occur 1-2 h after reperfusion (57).
The data presented imply that a combination of anesthesia and surgical trauma alone induced mild hyperglycemia, whereas anesthesia/surgery in combination with hemorrhage induced more severe hyperglycemia, both at the end of the hemorrhage period (90') and 60 min after fluid resuscitation (210'). It is unlikely that the hyperglycemia was from ingested food. Animals were fasted for 18-20 h, the basic preoperative and surgical procedures lasted at least 0.25 h, and the hemorrhage period lasted 90 min. Thus 19.75-21.75 h had elapsed since the rats were last permitted access to food. Although elevation of epinephrine and glucagon can stimulate glycogen breakdown, glycogenolysis is also an unlikely source for the extreme hyperglycemia of the hemorrhaged animals. Previous studies suggest that hepatic glycogen content is reduced over 90% following a 20- to 24-h fast (28). In support of this contention, data from Maitra et al. (33) suggest that adrenergic blockers and inhibition of glucagon had no effect on hemorrhage-induced hyperglycemia in rats fasted for 20 h. However, breakdown of liver or muscle glycogen may have contributed to the increase in blood glucose. Hyperglycemia, when combined with the severe hyperinsulinemia obtained following trauma and hemorrhage, is strongly suggestive of a rapid development of insulin.
Changes of serum insulin levels can vary in different injury models and with different time courses. In less severe forms of injury or very early following hemorrhage, serum insulin concentrations were sometimes found to decrease or not increase (13, 33, 45). However, in the later stages of the hemorrhage period or following resuscitation, there is a uniform responsiveness of pancreatic beta cells to glucose and plasma insulin concentrations rise in an attempt to control the hyperglycemia.
Many researchers (10, 15, 45) have demonstrated muscle insulin resistance in different animal models of injury. They include impairment of insulin stimulation of IRS-1, PI3-kinase, and Akt in damaged human skeletal muscle (15). The liver is a main source of gluconeogenesis, and insulin is one of the primary suppressors of hepatic gluconeogenesis and hepatic glucose output. However, little is known about hepatic insulin resistance following injury, and if it becomes resistant to insulin, the liver may contribute to the hyperglycemia. There is evidence that soon after hemorrhage and resuscitation, hepatic expression of the gluconeogenic gene glucose-6-phosphatase increases, suggesting insulin resistance in the liver (33); but this might be due to rising glucocorticoids, another regulator of glucose-6-phosphatase expression (32). Therefore, a direct examination of hepatic insulin signaling and any changes following hemorrhage was necessary to characterize hepatic insulin resistance.
Development of insulin resistance can be explained by changes in the number of insulin receptors, impaired insulin binding, faulty docking protein association with the activated insulin receptor, or a number of postreceptor defects, including disruption of one or more of the intracellular signaling pathways used by insulin. The two most widely studied and understood insulin signal-transduction pathways are the IRS1/2-PI3-kinase-Akt pathway and the Ras-MEK-ERK1/2 pathway. The present study indicated that insulin-induced PI3-kinase-Akt signaling was abolished by the end of the hemorrhage period and was still absent even following fluid resuscitation. At the same time points, exogenously added insulin continued to be capable of stimulating phosphorylation of ERK1/2 roughly 20-fold. This induction of P-ERK1/2 by insulin was approximately the same as the effects of insulin injection in animals before hemorrhage (T 0') and in animals subjected to surgery alone (T 90' and T 210'). This was true even though there was an elevation of basal ERK activation/phosphorylation following hemorrhage. Thus, even in the presence of highly elevated endogenous insulin, the liver was still responsive to exogenous insulin. Although not directly measured, this suggests that there were sufficient insulin receptors in the liver for a full response to insulin and that the insulin receptors were capable of activating at least some of the insulin-induced signaling pathways. Thus hemorrhage-induced hepatic insulin resistance differentially affects the PI3-kinase-Akt and MEK-ERK1/2 signaling pathways. This also suggests that effects of insulin mediated via the MEK-ERK pathway may still be functional following trauma and hemorrhage even when insulin responses mediated via PI3-kinase-Akt have been compromised.
The data presented demonstrate that insulin-induced PI3-kinase
signaling was abolished following hemorrhage, although further study is
needed to explore the mechanism of this impairment. Following hemorrhage, sepsis, or ischemic injury to the liver, serum levels of
many proinflammatory cytokines increase dramatically (2, 48,
49). It is known that proinflammatory cytokines, such as
TNF-, can result in insulin resistance of fat and muscle associated with Type 2 diabetes or obesity (14, 55, 62). However,
several studies failed to confirm these findings (18, 52),
and thus the effect of TNF-
on insulin resistance may be tissue
specific or model specific. Further studies are needed to explore
whether increased cytokines may contribute to the defects of
insulin-induced PI3-kinase signaling following trauma and hemorrhage.
Because there was a defect in the PI3-kinase signaling pathway, we examined whether this loss of signaling resulted in a loss of insulin action. The hepatic action of insulin needed to be one solely dependent on the PI3-kinase pathway. One of the hepatic actions of insulin, working via activation of the Akt kinase, is to Ser/Thr phosphorylate and inactivate forkhead transcription factor(s). Of particular importance for this discussion, forkhead rhabdomyosarcoma transcription factor (FKHR) is a major regulator of IGFBP-1 mRNA (20, 42, 50, 53, 54). Nonphosphorylated FKHR in the nucleus activates IGFBP-1 transcription. When FKHR is phosphorylated in response to insulin stimulation of the PI3-kinase pathway, it is excluded from the nucleus, the stimulatory action of FKHR is inhibited, and IGFBP-1 transcription and mRNA decrease. However, if the normal induction of the PI3-kinase pathway by insulin is compromised (when insulin levels are low or when the liver cannot respond well to insulin due to insulin resistance), the FKHR transcription factor remains in the nonphosphorylated state, and transcription of the IGFBP-1 gene is induced. Because there was a defect in the PI3-kinase signaling pathway following trauma and hemorrhage, it was asked whether this loss of PI3-kinase signaling resulted in a loss of insulin inhibition of the IGFBP-1 gene. Because there was a large increase of circulating insulin concentrations following hemorrhage, the measured increase in IGFBP-1 mRNA was not due to a deficit of insulin but must be due to hepatic insulin resistance. The strong correlation between insulin levels, or the glucose/insulin ratio, two measures of insulin resistance, and IGFBP-1 mRNA, a proposed measure of hepatic insulin resistance, suggests that IGFBP-1 mRNA may be a sensitive indicator of insulin resistance and, in particular, a defect in the induction of PI3-kinase signaling by insulin shortly after trauma and hemorrhage. An elevation in plasma IGFBP-1 is commonly observed in a variety of catabolic conditions (16, 25, 26). Its physiological effects following trauma and hemorrhage are unknown. However, recent work (4, 12) does suggest that IGFBP-1 can modify the effects of IGF-1 as well as having biological actions that are IGF-I independent. Further work is needed to study the time course of plasma IGFBP-1 levels and whether IGFBP-1 has a physiological role following trauma and hemorrhage.
One hypothesis of the physiological importance of insulin resistance following injury suggests that the resulting hyperglycemia enhances the glucose concentration gradient, increasing insulin-insensitive facilitative glucose transport into injured tissues and organs involved in the immunological response to stress (5, 34, 37). A second premise is that after hemorrhage, glucose acts as a nonpermeant solute, drawing fluid into the circulation in an attempt to maintain blood pressure (35, 37, 38). Acute increased hepatic gluconeogenesis could result from glycogenolysis or increases in blood lactate and glycerol immediately following trauma and hemorrhage. However, if the insulin resistance is prolonged, the protective effect of hyperglycemia is costly in terms of tissue protein loss, because muscle proteolysis acts as a source of amino acids for hepatic conversion to glucose resulting in muscle wasting (22).
These studies present data of early time points following trauma alone or trauma and hemorrhage. Thus we do not know whether hepatic insulin resistance also occurs at later time points following hemorrhage and, if so, whether the mechanism(s) resulting in insulin resistance changes with time. We also do not know whether insulin resistance in other tissues, such as muscle and fat, are due to similar or dissimilar alterations in insulin signaling. This early hepatic insulin resistance may occur concurrently with insulin resistance in other tissues, such as muscle and fat. This multitissue insulin resistance is the likely cause of hyperglycemia. Future studies will be needed to focus on these questions.
Although there are obvious differences between the rat model used in the present studies and the human patient, there are numerous parallels in the development of insulin resistance. In a recent publication (56), intensive insulin therapy was used to overcome insulin resistance and reduce blood glucose levels, which resulted in decreased morbidity and mortality among critically ill patients. Although these studies will need to be repeated and extended to other patient groups, this work suggests that a useful treatment protocol for future trauma patients may be intensive insulin therapy or treatment with pharmacological agents that can increase tissue sensitivity to endogenous insulin, resulting in greater long-term survival.
![]() |
ACKNOWLEDGEMENTS |
---|
We thank Z. F. Ba for assistance with the surgical techniques, the Univ. of Alabama Birmingham Clinical Nutrition Research Center and Dr. B. Gower for the insulin measurements, and Dr. M. Rechler for providing the IGFBP-1 cDNA probe.
![]() |
FOOTNOTES |
---|
This work was supported by grants from the American Diabetes Association (to J. L. Messina) and National Institutes of Health Grants DK-40456 (to J. L. Messina), GM-53008 (to P. Wang), and GM-R37-39519 (to I. H. Chaudry).
Address for reprint requests and other correspondence: J. L. Messina, Dept. of Pathology, Div. of Molecular and Cellular Pathology, Volker Hall, G019, 1670 Univ. Blvd., Univ. of Alabama at Birmingham, Birmingham, AL 35294-0019 (E-mail: messina{at}path.uab.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
September 25, 2002;10.1152/ajpgi.00217.2002
Received 7 June 2002; accepted in final form 10 September 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Andrejko, KM,
and
Deutschman CS.
Altered hepatic gene expression in fecal peritonitis: changes in transcription of gluconeogenic, beta-oxidative, and ureagenic genes.
Shock
7:
164-169,
1997[ISI][Medline].
2.
Ayala, A,
Wang P,
Ba ZF,
Perrin MM,
Ertel W,
and
Chaudry IH.
Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage.
Am J Physiol Regul Integr Comp Physiol
260:
R167-R171,
1991
3.
Ba, ZF,
Wang P,
Koo DJ,
Ornan DA,
Bland KI,
and
Chaudry IH.
Attenuation of vascular endothelial dysfunction by testosterone receptor blockade after trauma and hemorrhagic shock.
Arch Surg
136:
1158-1163,
2001
4.
Baxter, RC.
Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities.
Am J Physiol Endocrinol Metab
278:
E967-E976,
2000
5.
Carter, EA.
Insulin resistance in burns and trauma.
Nutr Rev
56, Suppl 1:
S170-S176,
1998[ISI][Medline].
6.
Cerchio, GM,
Moss GS,
Popovich PA,
Butler E,
and
Siegel DC.
Serum insulin and growth hormone response to hemorrhagic shock.
Endocrinology
88:
138-143,
1971[ISI][Medline].
7.
Chaudry, IH,
Sayeed MM,
and
Baue AE.
Insulin resistance in experimental shock.
Arch Surg
109:
412-415,
1974[ISI][Medline].
8.
Chaudry, IH,
Sayeed MM,
and
Baue AE.
Effect of adenosine triphosphate-magnesium chloride administration in shock.
Surgery
75:
220-227,
1974[ISI][Medline].
9.
Chaudry, IH,
Sayeed MM,
and
Baue AE.
Reversal of insulin resistance by ATP in hemorrhagic shock.
Can J Physiol Pharmacol
53:
859-865,
1975[ISI][Medline].
10.
Chaudry, IH,
Sayeed MM,
and
Baue AE.
Insulin resistance and its reversal by in vivo infusion of ATP in hermorrhagic shock.
Can J Physiol Pharmacol
54:
736-741,
1976[ISI][Medline].
11.
Clemens, MG,
Chaudry IH,
Daigneau N,
and
Baue AE.
Insulin resistance and depressed gluconeogenic capability during early hyperglycemic sepsis.
J Trauma
24:
701-708,
1984[ISI][Medline].
12.
Clemmons, DR.
Insulin-like growth factor binding proteins and their role in controlling IGF actions.
Cytokine Growth Factor Rev
8:
45-62,
1997[Medline].
13.
Clowes, GH, Jr,
Martin H,
Walji S,
Hirsch E,
Gazitua R,
and
Goodfellow R.
Blood insulin responses to blood glucose levels in high output sepsis and spetic shock.
Am J Surg
135:
577-583,
1978[ISI][Medline].
14.
Del Aguila, LF,
Claffey KP,
and
Kirwan JP.
TNF- impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells.
Am J Physiol Endocrinol Metab
276:
E849-E855,
1999
15.
Del Aguila, LF,
Krishnan RK,
Ulbrecht JS,
Farrell PA,
Correll PH,
Lang CH,
Zierath JR,
and
Kirwan JP.
Muscle damage impairs insulin stimulation of IRS-1, PI3-kinase, and Akt-kinase in human skeletal muscle.
Am J Physiol Endocrinol Metab
279:
E206-E212,
2000
16.
Fan, J,
Char D,
Bagby GJ,
Gelato MC,
and
Lang CH.
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor.
Am J Physiol Regul Integr Comp Physiol
269:
R1204-R1212,
1995
17.
Folli, F,
Saad MJ,
Backer JM,
and
Kahn CR.
Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat.
J Biol Chem
267:
22171-22177,
1992
18.
Furnsinn, C,
Neschen S,
Wagner O,
Roden M,
Bisschop M,
and
Waldhausl W.
Acute and chronic exposure to tumor necrosis factor- fails to affect insulin-stimulated glucose metabolism of isolated rat soleus muscle.
Endocrinology
138:
2674-2679,
1997
19.
Griffiths, RD,
Hinds CJ,
and
Little RA.
Manipulating the metabolic response to injury.
Br Med Bull
55:
181-195,
1999[Abstract].
20.
Guo, S,
Rena G,
Cichy S,
He X,
Cohen P,
and
Unterman T.
Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence.
J Biol Chem
274:
17184-17192,
1999
21.
Hiebert, JM,
Celik Z,
Soeldner JS,
and
Egdahl RH.
Insulin response to hemorrhagic shock in the intact and adrenalectomized primate.
Am J Surg
125:
501-507,
1973[ISI][Medline].
22.
Inculet, RI,
Finley RJ,
Duff JH,
Pace R,
Rose C,
Groves AC,
and
Woolf LI.
Insulin decreases muscle protein loss after operative trauma in man.
Surgery
99:
752-758,
1986[ISI][Medline].
23.
Lang, CH,
and
Dobrescu C.
In vivo insulin resistance during nonlethal hypermetabolic sepsis.
Circ Shock
28:
165-178,
1989[ISI][Medline].
24.
Lang, CH,
Dobrescu C,
and
Meszaros K.
Insulin-mediated glucose uptake by individual tissues during sepsis.
Metabolism
39:
1096-1107,
1990[ISI][Medline].
25.
Lang, CH,
Fan J,
Cooney R,
and
Vary TC.
IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis.
Am J Physiol Endocrinol Metab
270:
E430-E437,
1996
26.
Lang, CH,
Liu X,
Nystrom GJ,
and
Frost RA.
Acute response of IGF-I and IGF binding proteins induced by thermal injury.
Am J Physiol Endocrinol Metab
278:
E1087-E1096,
2000
27.
Lange, MP,
Dahn MS,
and
Jacobs LA.
The significance of hyperglycemia after injury.
Heart Lung
14:
470-472,
1985[ISI][Medline].
28.
Ljungqvist, O,
Boija PO,
Esahili H,
Larsson M,
and
Ware J.
Food deprivation alters liver glycogen metabolism and endocrine responses to hemorrhage.
Am J Physiol Endocrinol Metab
259:
E692-E698,
1990[Abstract].
29.
Long, CL,
Kinney JM,
and
Geiger JW.
Nonsuppressability of gluconeogenesis by glucose in septic patients.
Metabolism
25:
193-201,
1976[ISI][Medline].
30.
Maassen, JA,
and
Ouwens DM.
Mechanism of insulin action.
Fron Horm Res
22:
201-221,
1997[ISI].
31.
Maitra, SR,
Gestring M,
and
Maghrabi MR.
Alterations in hepatic 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and glucose-6-phosphatase gene expression after hemorrhagic hypotension and resuscitation.
Shock
8:
385-388,
1997[ISI][Medline].
32.
Maitra, SR,
Wang S,
and
Maghrabi MR.
Effects of RU486 on Glu-6-pase gene expression in hemorrhage and resuscitation.
Shock
14:
578-581,
2000[ISI][Medline].
33.
Maitra, SR,
Wang S,
and
Maghrabi MR.
Regulation of liver and kidney glucose-6-phosphatase gene expression in hemorrhage and resuscitation.
Acad Emerg Med
7:
731-738,
2000
34.
Maitra, SR,
Wojnar MM,
and
Lang CH.
Alterations in tissue glucose uptake during the hyperglycemic and hypoglycemic phases of sepsis.
Shock
13:
379-385,
2000[ISI][Medline].
35.
Menguy, R,
and
Masters YF.
Influence of hyperglycemia on survival after hemorrhagic shock.
Adv Shock Res
1:
43-54,
1978[Medline].
36.
Messina, JL,
Hamlin J,
and
Larner J.
Insulin-mimetic actions of wheat germ agglutinin and concanavalin A on specific mRNA levels.
Arch Biochem Biophys
254:
110-115,
1987[ISI][Medline].
37.
Michie, HR.
Metabolism of sepsis and multiple organ failure.
World J Surg
20:
460-464,
1996[ISI][Medline].
38.
Mizock, BA.
Alterations in carbohydrate metabolism during stress: a review of the literature.
Am J Med
98:
75-84,
1995[ISI][Medline].
39.
Moss, GS,
Cerchio GM,
Siegel DC,
Popovich PA,
and
Butler E.
Serum insulin response in hemorrhagic shock in baboons.
Surgery
68:
34-39,
1970[ISI][Medline].
40.
Myers, MG, Jr,
Sun XJ,
and
White MF.
The IRS-1 signaling system.
Trends Biochem Sci
19:
289-293,
1994[ISI][Medline].
41.
Nakae, J,
and
Accili D.
The mechanism of insulin action.
J Pediatr Endocrinol Metab
12, Suppl3:
721-731,
1999[ISI][Medline].
42.
Nakae, J,
Park BC,
and
Accili D.
Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway.
J Biol Chem
274:
15982-15985,
1999
43.
Nelson, KM,
and
Filkins JP.
Effect of traumatic injury on sensitivity to insulin.
Circ Shock
6:
285-295,
1979[ISI][Medline].
44.
Nordenstrom, J,
Sonnenfeld T,
and
Arner P.
Characterization of insulin resistance after surgery.
Surgery
105:
28-35,
1989[ISI][Medline].
45.
Raymond, RM,
Harkema JM,
and
Emerson TE.
Skeletal muscle insulin resistance during Escherichia coli bacteremic shock in the dog.
Surgery
90:
853-859,
1981[ISI][Medline].
46.
Rechler, MM.
Insulin-like growth factor binding proteins.
Vitam Horm
47:
1-114,
1993[ISI][Medline].
47.
Rechler, MM,
Ooi GT,
Suh D,
and
Tseng L.
Rapid regulation of insulin-like growth factor binding protein-1 transcription by insulin in vivo and in vitro.
Adv Exp Med Biol
343:
227-236,
1993[Medline].
48.
Remick, DG,
Colletti LM,
Scales WA,
McCurry KR,
and
Campbell DA.
Cytokines and extrahepatic sequelae of ischemia-reperfusion injury to the liver.
Ann NY Acad Sci
723:
271-283,
1994[ISI][Medline].
49.
Remick, DG,
Newcomb DE,
Bolgos GL,
and
Call DR.
Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.
Shock
13:
110-116,
2000[ISI][Medline].
50.
Rena, G,
Guo S,
Cichy SC,
Unterman TG,
and
Cohen P.
Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B.
J Biol Chem
274:
17179-17183,
1999
51.
Rosato, EF,
Vemulapalli P,
and
Lang CH
and Lanza-Jacoby S. Insulin stimulates lipoprotein lipase activity and synthesis in adipocytes from septic rats.
J Surg Res
73:
73-79,
1997[ISI][Medline].
52.
Schreyer, SA,
Chua SC, Jr,
and
LeBoeuf RC.
Obesity and diabetes in TNF- receptor-deficient mice.
J Clin Invest
102:
402-411,
1998
53.
Tang, ED,
Nunez G,
Barr FG,
and
Guan KL.
Negative regulation of the forkhead transcription factor FKHR by Akt.
J Biol Chem
274:
16741-16746,
1999
54.
Tomizawa, M,
Kumar A,
Perrot V,
Nakae J,
Accili D,
and
Rechler MM.
Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcription factor FKHR.
J Biol Chem
275:
7289-7295,
2000
55.
Valverde, AM,
Teruel T,
Navarro P,
Benito M,
and
Lorenzo M.
Tumor necrosis factor-alpha causes insulin receptor substrate-2-mediated insulin resistance and inhibits insulin-induced adipogenesis in fetal brown adipocytes.
Endocrinology
139:
1229-1238,
1998
56.
Van den, BG,
Wouters P,
Weekers F,
Verwaest C,
Bruyninckx F,
Schetz M,
Vlasselaers D,
Ferdinande P,
Lauwers P,
and
Bouillon R.
Intensive insulin therapy in the critically ill patients.
N Engl J Med
345:
1359-1367,
2001
57.
Verma, S,
Fedak PW,
Weisel RD,
Butany J,
Rao V,
Maitland A,
Li RK,
Dhillon B,
and
Yau TM.
Fundamentals of reperfusion injury for the clinical cardiologist.
Circulation
105:
2332-2336,
2002
58.
Wang, P,
Ba ZF,
Galardy RE,
and
Chaudry IH.
Administration of a matrix metalloproteinase inhibitor after hemorrhage improves cardiovascular and hepatocellular function.
Shock
6:
377-382,
1996[ISI][Medline].
59.
Wang, P,
Singh G,
Rana MW,
Ba ZF,
and
Chaudry IH.
Preheparinization improves organ function after hemorrhage and resuscitation.
Am J Physiol Regul Integr Comp Physiol
259:
R645-R650,
1990
60.
White, MF,
and
Kahn CR.
The insulin signaling system.
J Biol Chem
269:
1-4,
1994
61.
Whitehead, JP,
Clark SF,
Urso B,
and
James DE.
Signalling through the insulin receptor.
Curr Opin Cell Biol
12:
222-228,
2000[ISI][Medline].
62.
Youd, JM,
Rattigan S,
and
Clark MG.
Acute impairment of insulin-mediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-.
Diabetes
49:
1904-1909,
2000[Abstract].
|
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Visit Other APS Journals Online |